Emmessar Biotech & Nutrition Limited (BOM:524768)

India · Delayed Price · Currency is INR

23.90

+0.22 (0.93%)

At close: Aug 17, 2026

BOM:524768 Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	23.78	24.07	21.35	20.42	25.15	17.73
Revenue Growth	-12.25%	12.75%	4.55%	-18.82%	41.83%	-79.03%
Gross Profit	23.03	23.19	19.49	18.42	20.81	16.38
Operating Income	5.14	5.82	4.74	3.24	7.31	4.86
Net Income	3.96	4.36	3.16	7.5	5.04	4.75
Earnings Per Share	0.74	0.81	0.61	1.48	1.01	0.95
EPS Growth	-3.90%	32.79%	-58.78%	46.77%	5.97%	-67.21%

Revenue by Segment

Fiscal Year	TTM	FY 2026	FY 2025
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025
Healthcare	3.37	3.71	6.11
Rent on Leasehold Land	16.53	16.53	15.24
Others	3.88	3.83	-
Total	23.78	24.07	21.35

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	73.27	73.27	77.81	61.92	52	45.92
Total Debt	-	-	-	1.09	0.82	-
Net Cash (Debt)	73.27	73.27	77.81	60.82	51.18	45.92
Net Cash Growth	6.47%	-5.85%	27.94%	18.83%	11.46%	85.27%
Net Cash Per Share	13.60	13.61	15.58	12.17	10.24	9.19

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	2.65	2.24	6.45	3.76	22.7
Capital Expenditures	-	-0.09	-	-	-0.26	-3.06
Free Cash Flow	-	2.57	2.24	6.45	3.5	19.64
Free Cash Flow Growth	-	14.66%	-65.28%	84.22%	-82.19%	321.44%

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	96.84%	96.35%	91.32%	90.21%	82.75%	92.38%
Operating Margin	21.61%	24.19%	22.19%	15.87%	29.07%	27.43%
Pretax Margin	21.50%	24.08%	44.89%	39.80%	38.45%	52.54%
Profit Margin	16.66%	18.11%	14.81%	36.72%	20.03%	26.81%
FCF Margin	-	10.66%	10.48%	31.57%	13.91%	110.78%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 18, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	32.50	27.00	48.02	19.81	24.59	28.90
P/FCF Ratio	46.53	45.87	67.84	23.04	35.41	7.00
PS Ratio	5.02	4.89	7.11	7.27	4.93	7.75